연구동향 분석

주의력결핍 과잉행동장애 한국형 치료 권고안(III)

유희정 양수진 신동원 김지훈 유한익 홍현주 김붕년 안동현 천근아 강화연 2007년

논문상세정보
인용/피인용

' 주의력결핍 과잉행동장애 한국형 치료 권고안(III)' 의 참고문헌

  • Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial
    Martins S 14 195-206 [2004]
  • US Department of Health and Human Services NPT-CERHR expert panel report on the repro-ductive and developmental toxicity of methylphenidate
    March - [2005]
  • The use of trazodone as a hypnotic: a critical review
    James SP 65 752-755 [2004]
  • The treatment of ADHD in Touretes syndrome: a double-blind placebo controlled study with clonidine and desipramine
    Singer HV 95 74-81 [1995]
  • Sudden death from cardiac causes in children and young adults
    Liberthson R 334 1039-1044 [1996]
  • Stimulant-related reductions of growth rates in the PATS
    Swanson J 45 1304-1313 [2006]
  • Stimulant treatment over five years: adherence, efectiveness, and adverse efects
    Charach A 43 559-567 [2004]
  • Stimulant medications
    Greenhil LL 38 503-512 [1999]
  • Stim-ulant therapy and seizure risk in children with ADHD
    Hemer SA 24 99-102 [2001]
  • Steady-state pharmacokinetics of bupropion SR in juvenile patients
    Davis WB 44 349-357 [2005]
  • Steady-state clinical pharmacokinetics of bupropion extended-release in youths
    Davis WB 45 1503-1509 [2006]
  • Side effects of methylphenidate and dexamphetamine in children with atentions deficit hype-ractivity disorder: a double-blind, crosover trial
    Efron D 100 662-666 [1997]
  • Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit/ hyperactivity disorder
    Wolraich ML 108 883-892 [2001]
  • Psychotic side efects of psycho-stimulants: a 5-year review
    Cherland E 44 811-813 [1999]
  • Predictors of adult height and weight in boys treated with me-thylphenidate for childhod behavior problems
    Kramer JR 29 513-528 [2000]
  • Placebo-controled evaluation of Ritalin side effects
  • Pediatric dosage handbook, 11th ed
    Taketomo CK - [2004]
  • Pediatric dosage hand-bok, 1th ed
    Taketomo CK - [2004]
  • Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controled study
    Michelson D 159 1896-1901 [2002]
  • Once-daily OROS methylphenidate is safe and wel tolerated in adolescents with attention-deficit/hype-ractivity disorder
    McGough J 16 351-356 [2006]
  • National Toxicology Program, US Department of Health and Human Services. NPT-CERHR expert panel report on the repro-ductive and developmental toxicity of methylphenidate
    - [2005]
  • National Institute of Mental Health Multimodal Treatment Study of ADHD Folow-up: Changes in Effectiveness and Growth After the End of Treatment
    MTA Cooperative Group 113 762-769 [2004]
  • Modafinil improves cognition and response inhibiton in adult at-tention-deficit/hyperactivity disorder
    Turner DC 55 1031-1040 [2004]
  • Methylphenidate-induced mania in prepubertal child
    Koehler-Troy C 47 566-567 [1986]
  • Methylphenidate hallucinosis
    Lucas AR 217 1079-1081 [1971]
  • Methyl-phenidate-induced delusional disorder in a child with atention deficit disorder with hyperactivity
    Bloom AS 27 88-89 [1988]
  • Melatonin for treatment of sleping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study
    Tjon Pian Gi CV 162 554-555 [2003]
  • Long-term tolerability and effectiveness of once-daily mixed amethylphenidateetamine salts(Adderall XR) in children with ADHD
    McGough JJ 44 530-538 [2005]
  • Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms: A randomized, double-blind, placebo-controlled trial
    Gillberg C 54 857-864 [1997]
  • Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder
    Gadow KD 56 330-336 [1999]
  • Impairment and deportment responses to dife-rent methylphenidate doses in children with ADHD: the MTA tit-ration trial
    Greenhil L 49 180-187 [2001]
  • How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescent? A meta-analysis
    Schachter HM 165 1475-1488 [2001]
  • Guanfacine for treatment of aten-tion-deficit hyperactivity disorder in boys
    Horrigan JP 5 215-223 [1995]
  • Growth deficits in ADHD children revisited: evidence for disorder-asociated growth delays?
    Spencer TJ 35 1460-1469 [1996]
  • Evaluation of efficacy and safety or OROS me-thylphenidate HCL(methylphenidate) extended release tablets, methylphenidate tid, and placebo in children with ADHD
    Wolraich ML 47 36A- [2000]
  • European clinical guidelines for hyper-kinetic disorder - first upgrade
    Taylor E 13 7-30 [2004]
  • Equivalent ef-fects of stimulant treatment for ADHD during childhod and ad-olescence
    Smith BH 37 314-321 [1998]
  • Epilepsy and attention deficit/hyperactivity disorder: is methylphenidate safe and effective
    Gross-Tsur V J Pediatr 130 670-674 [1997]
  • Epilepsy and atention deficit/hyperactivity disorder: is me-thylphenidate safe and effective?
    Gros-Tsur V 130 670-674 [1997]
  • Electrophysiologic and hemodynamic efects of chronic oral therapy with the alpha2-agonists clonidine and tiamenidine in hypertensive volunteers
    Roden DM 43 648-654 [1988]
  • Efficacy and safety of imediate-release methylphe-nidate treatment for prescholers with ADHD
    Greenhil L 45 1284-1293 [2006]
  • Effects of moda-finil on cognitive and meta-cognitive performance
    Baranski JV 19 323-332 [2004]
  • Does stimulant therapy of atention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature
    Wilens TE 111 179-185 [2003]
  • Does prolonged therapy with a long-acting stimulant supres growth in children with ADHD?
    Spencer TJ 45 527-537 [2006]
  • Do typical clinical doses of methylphe-nidate cause tics in children treated for attention-deficit hyperac-tivity disorder?
    Law SF 38 944-951 [1999]
  • Development of a new once-a day formulation of me-thylphenidate for the treatment of attention-deficit/hyperactivity disorder. Proof-of concept and proof-of product studies
    Swanson J 60 204-211 [2003]
  • Compliance study of methyl-phenidate IR in the treatment of ADHD
    Hwang JW 15 160-167 [2004]
  • Clonidine for slep dis-turbances asociated with ADHD
    Wilens TE 33 424-426 [1994]
  • Clinical practice guideline: treatment of the school-aged children with atention-deficit/hy-peractivity disorder
    American Academy of Pediatrics 108 1033-1044 [2001]
  • Bupropion hydrochloride in attention deficit disorder with hyperactivity
    Coners CK 35 1314-1321 [1996]
  • Bupropion exacerbates tics in children with ADHD and Tourette's disorder
    Spencer T 32 211-214 [1993]
  • Atomoxetine pharmacokinetics in children and adolescents with atention deficit hyperactivity disorder
    Witcher JW 13 53-63 [2003]
  • Atomoxetine in the treatment of children and adolescents with atention-deficit/hyperactivity disorder: a ran-domized, placebo-controled, dose-response study
    Michelson D 08 e83- [2001]
  • Atomoxetine in adults with ADHD: two ran-domized, placebo-controled studies
    Michelson D 53 112-120 [2003]
  • Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depresive or anx-iety symptoms
    Kratochvil CJ 44 915-924 [2005]
  • Analog classroom assessment of a once-daily mixed amethylphenidatetamine formulation, SLI381(Adderal XR), in children with ADHD
    McCracken JT 42 673-683 [2003]
  • An observational study for evaluation of effi-cacy, safety and parental satisfaction of methylphenidate-OROS in children with ADHD
    Kim B 16 279-285 [2005]
  • AHA scientific statement: cardiovascular monitoring of children and adolescent receiving psychotropic drugs
    Gutgesell H 38 979-982 [1999]
  • A randomized, placebo-controled trial of OROS methylphenidate in adults with atention-deficit/hyperac-tivity disorder
    Biederman J 59 829-835 [2006]
  • A randomized, double-blind, placebo-con-trolled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder
    Greenhil L 45 503-511 [2006]
  • A ran-domized, double-blind, placebo-controled, paralel-group study of SLI381(Adderal XR) in children with atention-deficit/hype-ractivity disorder
    Biederman J 110 258-266 [2002]
  • A placebo-controled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder
    Scahil L 158 1067-1074 [2001]
  • A meta-analysis of clonidine for symptoms of ADHD
    Connor DF 38 1551-1559 [1999]
  • A double-blind, placebo-controlled study of modified-release methylphenidate in children with atention-deficit/hype-ractivity disorder
    Greenhill L 109 e39- [2002]
  • A double-blind, pla-cebo-controlled study of modified-release methylphenidate in children with atention-deficit hyperactivity disorder
    Greenhill LL 109 e39- [2002]
  • A dose-response study of OROS methyl-phenidate in children with attention-deficit/hyperactivity disorder
    Stein MA 112 e404- [2003]
  • A comparison of once-daily and divided doses of modafinil in children with atention-deficit/hyperactivity disor-der: a randomized, double-blind, and placebo-controled study
    Biederman J 67 727-735 [2006]
  • A chart review of cyproheptadine for sti-mulant-induced weight los
    Daviss WB 14 65-73 [2004]